SCHEMBL4696880

SCHEMBL4696880

O=[N+]([O-])c1cc(C(F)(F)F)ccc1Oc1cncc(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
TTR P02766 1/20 0.49
PPOX P50336 1/20 0.49
HPGD P15428 3/20 0.47
LMNA P02545 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
EPAS1 Q99814 1/20 0.47
MAPT P10636 5/20 0.47
POLB P06746 2/20 0.47
CCR6 P51684 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP2C9 P11712 2/20 0.46
MAPK1 P28482 1/20 0.46
MASP2 O00187 1/20 0.46
F2 P00734 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2932928 0.81 LMNA (0.51) TDP1MEN1KMT2AHPGDLMNA
SCHEMBL16866217 0.81 HPGD (0.55) TDP1MEN1KMT2ATTRPPOX
SCHEMBL31090851 0.80 LMNA (0.62) TDP1MEN1KMT2ATTRPPOX
SCHEMBL14677574 0.80 LMNA (0.62) TDP1MEN1KMT2ATTRPPOX
SCHEMBL10980033 0.80 MAPT (0.61) TDP1MEN1KMT2ATTRPPOX
SCHEMBL4693866 0.79 HPGD (0.55) TDP1MEN1KMT2ATTRHPGD
SCHEMBL5719955 0.79 TDP1 (0.61) TDP1MEN1KMT2ATTRPPOX
SCHEMBL4697665 0.78 L3MBTL1 (0.56) MEN1KMT2AHPGDLMNASMN1; SMN2
SCHEMBL4697642 0.78 PPARG (0.52) MEN1KMT2AEPAS1MAPTNPSR1
SCHEMBL31090831 0.78 MAPT (0.60) TDP1MEN1KMT2ATTRPPOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1053227-B1 PPAR-GAMMA MODULATORS AMGEN INC (US) 2008-11-05 EP disclosed
US-6200995-B1 PYRIDYLOXYBENZENESULFONAMIDE DERIVATIVES; DIABETES, OBESITY TULARIK INC. 2001-03-13 US disclosed